Inmunohistoquímica en cirugía micrográfica de Mohs: avances en el tratamiento del lentigo maligno en el Instituto Nacional de Cancerología de Colombia
Loading...
Date
2025-09-09
Journal Title
Journal ISSN
Volume Title
Publisher
Revista Colombiana de Cancerología
Abstract
Lentigo maligna is the most common type of melanoma in situ worldwide,
characterized by significant subclinical extension and high recurrence rates
following conventional surgery. For this reason, Mohs micrographic surgery
is considered a first-line treatment. The use of immunohistochemistry in
Mohs micrographic surgery for the treatment of lentigo maligna has proven
to enhance outcomes not only in histologic evaluation but also in the
speed of surgical sample processing, thereby increasing the precision and
efficiency of the procedure. Consequently, its implementation began at
the Functional Dermatology Unit of the Instituto Nacional de Cancerología
(Colombia) (INC) in 2024. This article describes the application of this
immunohistochemistry technique in Mohs micrographic surgery for the
treatment of lentigo maligna at the INC.
Description
This article describes the application of this
immunohistochemistry technique in Mohs micrographic surgery for the
treatment of lentigo maligna at the INC.
Keywords
lentigo maligna, melanoma, skin neoplasms, mohs micrographic surgery, immunohistochemistry
Citation
Bravo-Mora C, Rojas-Angarita P, Leal-Reina H, Rocha-Aguirre J, González-Cardona L. Inmunohistoquímica en cirugía micrográfica de Mohs: avances en el tratamiento del lentigo maligno en el Instituto Nacional de Cancerología de Colombia. Rev Col Cancerol. 2025;29(3):118-22.